Horng-Jyh Harn,Shinn-Zong Lin,Tzyy-Wen Chiou,Po-Cheng Lin
申请号：
US13109619
公开号：
US20120178803A1
申请日:
2011.05.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Provided is a method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells in a subject, comprising administrating to the subject an effective amount of an active ingredient selected from the group consisting of (Z)-butylidenephthalide of formula (I), a pharmaceutically acceptable salt of (Z)-butylidenephthalide, a pharmaceutically acceptable ester of (Z)-butylidenephthalide, and combinations thereof:
